GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Total Stockholders Equity

Halberd (Halberd) Total Stockholders Equity : $-0.93 Mil (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Total Stockholders Equity?

Halberd's Total Stockholders Equity for the quarter that ended in Jul. 2023 was $-0.93 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Halberd's Book Value per Share for the quarter that ended in Jul. 2023 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Halberd's Debt-to-Equity for the quarter that ended in Jul. 2023 was -0.16.


Halberd Total Stockholders Equity Historical Data

The historical data trend for Halberd's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Total Stockholders Equity Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Total Stockholders Equity
-0.04 -0.73 -0.93

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Total Stockholders Equity -0.04 -0.73 -0.93

Halberd  (OTCPK:HALB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Halberd's Book Value per Share for the quarter that ended in Jul. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Halberd's Debt-to-Equity for the quarter that ended in Jul. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Halberd's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236